reviewJAMA NeurologyNov 2, 2020HYBRID OA

Burden of Neurological Disorders Across the US From 1990-2017

G2GBD 2017 US Neurological Disorders CollaboratorsVLValery L. FeiginTVTheo VosFAFares AlahdabAMArianna Maever L. Amit

University of Washington · Institute for Health Metrics and Evaluation · +58 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

Importance

Accurate and up-to-date estimates on incidence, prevalence, mortality, and disability-adjusted life-years (burden) of neurological disorders are the backbone of evidence-based health care planning and resource allocation for these disorders. It appears that no such estimates have been reported at the state level for the US.

Objective

To present burden estimates of major neurological disorders in the US states by age and sex from 1990 to 2017. Design, Setting, and Participants: This is a systematic analysis of the Global Burden of Disease (GBD) 2017 study. Data on incidence, prevalence, mortality, and disability-adjusted life-years (DALYs) of major neurological disorders were derived from the GBD 2017 study of the 48 contiguous US states, Alaska, and Hawaii. Fourteen major neurological disorders were analyzed: stroke, Alzheimer disease and other dementias, Parkinson disease, epilepsy, multiple sclerosis, motor neuron disease, migraine, tension-type headache, traumatic brain injury, spinal cord injuries, brain and other nervous system cancers, meningitis, encephalitis, and tetanus. Exposures: Any of the 14 listed neurological diseases. Main Outcome and Measure: Absolute numbers in detail by age and sex and age-standardized rates (with 95% uncertainty intervals) were calculated.

Citation impact

622
total citations
FWCI
27.30
Percentile
100%
References
32
Citations per year

Authors

59

Topics & keywords

Keywords
  • Medicine
  • Stroke (engine)
  • Pediatrics
  • Incidence (geometry)
  • Disease
  • Disease burden
  • Migraine
  • Burden of disease
No related works found for this paper.

Funding